ASX:CLL Collerina Cobalt (CLL) Stock Price, News & Analysis → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free CLL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. About Collerina Cobalt Stock (ASX:CLL)Collerina Cobalt Limited engages in the acquisition, exploration, and development of mineral deposits in Australia and Indonesia. The company explores for gold, copper, nickel, and cobalt. It holds interest in the Collerina project covering an area of 150 square kilometers located to the south of Nyngan in central New South Wales; and the Wonogiri project covering an area of approximately 3,928 hectares located in central Java, Indonesia. The company was formerly known as Augur Resources Ltd and changed its name to Collerina Cobalt Limited in May 2017. Collerina Cobalt Limited is headquartered in Sydney, Australia.Read More Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… CLL Stock News HeadlinesApril 8, 2023 | abcnews.go.comDoctors say former Italian Premier Silvio Berlsconi is being treated for a lung infection and has long had leukemiaFebruary 27, 2023 | forbes.comBest Business Cell Phone Plans Of 2023February 26, 2023 | marketwatch.comCobalt Hydroxide Market Size in 2023 SHARE, TRENDS till 2026February 19, 2023 | benzinga.comChronic Lymphocytic Leukemia (CLL) Global Market Report 2023: Featuring BMS, Autolus Therapeutics & Sian Wuhan Medical TechnologyOctober 16, 2022 | washingtonpost.comHave you exercised your body fat lately?See More Headlines Company Calendar Last Earnings3/16/2018Today5/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Copper Sub-IndustryN/A Current SymbolASX:CLL CUSIPN/A CIKN/A Webwww.augur.com.au Phone+61-2-93003310FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares567,100,032Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Rimas KairaitisMD & DirectorMr. Peter James Nightingale B.Econ (Age 61)CA, CFO & Director Mr. Michael CoreyHead of ExplorationMr. Richard James Edwards BComCPA, SA Fin, FGIA, Company Sec.Key CompetitorsAlma MetalsASX:ALMAntofagastaOTCMKTS:ANFGFArizona Sonoran CopperOTC:ASCUFAustral Resources AustraliaASX:AR1Capstone CopperOTCMKTS:CSCCFView All Competitors CLL Stock Analysis - Frequently Asked Questions How were Collerina Cobalt's earnings last quarter? Collerina Cobalt Limited (ASX:CLL) announced its quarterly earnings results on Friday, March, 16th. The company reported $0.00 earnings per share for the quarter. This page (ASX:CLL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
